Objective
=========

To investigate HIV drug resistance and its influencing factors, and then provide scientific evidence for antiretroviral therapy and reducing drug resistance.

Methods
=======

Questionnaires and blood sample collection for drug resistance detection were conducted among 109 treated cases and 84 non-treated cases. Viral load was detected by NASBA and drug resistance was measured by nested PCR.

Results
=======

The viral load of 95 cases (27 treated cases and 68 non-treated cases) was more than 1 000 copies/ml. The rate of drug resistance of treated and non-treated group was 40.74% and10.29% respectively (see Table [1](#T1){ref-type="table"}). The rate of different drug resistance was higher significantly in treated group than in no-treated group. However, the sensitive of different drug resistance was lower significantly in treated group than in no-treated group (see Table [2](#T2){ref-type="table"}). Therapy schedule of 17 treated cases was stopped due to a variety of reasons, such as death, dizziness, liver damage, bellyache, et al (see Table [3](#T3){ref-type="table"}). Except for five death cases, two suicides were discovered at 16 and 42 days respectively after stopping therapy.

###### 

The results of drug resistance detection in 95 cases with AIDS

  Group                  No.   Low-midrange resistance (%)   Height drug resistance (%)   Total of resistance (%)
  ---------------------- ----- ----------------------------- ---------------------------- -------------------------
  Stopping therapy       12    0 (0.00)                      3 (25.00)                    3 (25.00)
  Single therapy         11    0 (0.00)                      6 (54.55)                    6 (54.55)
  Therapeutic alliance   4     0 (0.00)                      2 (50.00)                    2 (50.00)
  No therapy             68    6 (8.82)                      1 (1.47)                     7 (10.29)

###### 

The results of resistance detection of different drugs among 95 cases

                                        Drug resistance                
  ------------ ----- ---- ------------- ----------------- --- ---- --- ------------
  Therapy      DDI   27   19 (70.37)    1                 1   6    0   8 (29.63)
               D4T   27   24 (88.89)    2                 1   0    0   3 (11.11)
               EFV   27   15 (55.56)    0                 1   9    2   12 (44.44)
               NVP   27   16 (59.26)    0                 0   10   1   11 (40.74)
  No therapy   DDI   68   66 (97.06)    1                 0   0    3   4 (5.88)
               D4T   68   68 (100.00)   1                 0   0    4   5 (7.35)
               EFV   68   65 (95.58)    1                 2   0    0   3 (4.41)
               NVP   68   65 (95.58)    1                 2   1    0   3 (4.41)

###### 

The reasons of stopping therapy

  Course of treatment (Months)   Death       Liver damage   Dizziness   Skin damage   Bellyache   Total (%)
  ------------------------------ ----------- -------------- ----------- ------------- ----------- -----------
  0∼                             1           1              3           \-            \-          5 (29.41)
  1∼                             2           2              1           1             1           7 (41.18)
  2∼                             2           \-             1           \-            \-          3 (17.65)
  ...                                                                                             
  7∼                                         1                          1                         2 (11.76)
  Total (%)                      5 (29.41)   4 (23.53)      5 (29.41)   2 (11.76)     1 (5.88)    17 (100)

Conclusion
==========

Antiviral therapy can effectively reduce the viral load and inhibit viral replication. Drug resistance exists differently among treated and non-treated HIV/AIDS cases. HIV gene mutation may be the key reason for drug resistance.
